Adamis Pharmaceuticals Corp. Company Profile (NASDAQ:ADMP)

Analyst Ratings

Consensus Ratings for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (235.57% upside)

Analysts' Ratings History for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2016Maxim GroupLower Price TargetBuy$17.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2015MizuhoInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/2/2016David J MarguglioVPSell700$9.00$6,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016David J MarguglioSVPSell4,000$8.08$32,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016David J MarguglioSVPSell4,860$10.00$48,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016David J MarguglioSVPSell4,860$9.17$44,566.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016David J MarguglioSVPSell1,140$9.00$10,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016David J MarguglioSVPSell12,000$7.52$90,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Robert B RothermelDirectorBuy7,000$3.33$23,310.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015David J MarguglioSVPSell200$5.00$1,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015David J MarguglioSVPSell2,200$5.01$11,022.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015David J MarguglioSVPSell11,800$7.09$83,662.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015David J MarguglioSVPSell7,000$6.45$45,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell12,076$6.41$77,407.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell38,000$6.40$243,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell30,000$6.75$202,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015David J MarguglioVPSell7,000$6.18$43,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2014David J MarguglioSVPSell12,228$6.09$74,468.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2014David J MarguglioVPSell772$6.00$4,632.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014David J MarguglioSVPSell4,000$5.18$20,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014William C DenbyDirectorBuy2,500$5.06$12,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2014Robert B RothermelDirectorBuy5,500$4.03$22,165.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014David J MarguglioSVPSell4,000$5.56$22,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell7,015$0.57$3,998.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell40,000$0.56$22,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell67,960$0.57$38,737.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell10,328$0.56$5,783.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell95,000$0.56$53,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell141,224$0.57$80,497.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
DateHeadline
07/29/16 11:18 AMAdamis Pharmaceuticals (ADMP) Enters $11.1M Subscription Agreements Direct Offering
07/29/16 08:08 AMAdamis Pharmaceuticals Announces $11.1 Million Registered Direct Offering - [at noodls] - SAN DIEGO, July 29, 2016 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic ...
07/28/16 05:09 AMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
07/22/16 07:18 PMMaxim Group recorded (NASDAQ:ADMP) Adamis Pharmaceuticals, scaling down its target price to $10 earlier today
07/22/16 10:29 AMChecking in on Stock Volatility for: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily
07/21/16 07:53 PMAdamis Pharmaceuticals (ADMP) Says Allergan's (AGN) Watson Elected to Terminate Epinephrine PFS Agreement
07/21/16 02:18 PMStock Moving Lower for the Month; Investor Update on Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily
07/21/16 02:18 PMAdamis Pharmaceuticals (ADMP) Says Allergan's (AGN) Watson Elected to Terminate Epinephrine PFS Agreement - StreetInsider.com
07/21/16 10:48 AMAllergan backs out of deal with Adamis Pharma to commercialize Epinephrine Pre-Filled Syringe
07/21/16 10:48 AMAdamis Pharmaceuticals Provides Update On License Agreement with Allergan plc
07/16/16 10:42 AMAdamis Pharmaceuticals Corporation Stock Momentum Hits Weakness - CML News
07/14/16 11:11 AMEye on Stock Volatility for: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily
07/13/16 07:52 PMAdamis Pharmaceuticals : Announces Private Placement
07/12/16 02:20 PMAdamis Pharmaceuticals (ADMP) Announces 1.7M Share Private Placement of Convertible Preferred Stock - StreetInsider.com
07/08/16 02:20 PMWhat Will Happen to Adamis Pharmaceuticals Corp Next? The Stock Just Declined A Lot - Press Telegraph
07/08/16 02:20 PMHeightened Volatility Check on: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily
07/08/16 02:20 PMAdamis Pharmaceuticals Corporation Realized Volatility Hits Extreme Level - CML News
07/06/16 07:05 AMBroker Outlook For Adamis Pharmaceuticals Corporation (ADMP) - Fiscal Standard
07/01/16 02:19 PMNew Broker Ratings For Adamis Pharmaceuticals Corporation (ADMP) - FTSE News
07/01/16 02:19 PMNew Broker Ratings For Adamis Pharmaceuticals Corporation (ADMP) - FTSE News
06/29/16 02:16 PMShares Entering Oversold Area: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Press Telegraph
06/29/16 02:16 PMAdamis Pharmaceuticals Corporation (ADMP) Current Analyst Ratings - Fiscal Standard
06/28/16 02:32 PMCheck on Share Volatility: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily
06/27/16 03:54 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K/A, Financial Statements and Exhibits -
06/27/16 07:04 AMAdamis Pharmaceuticals Corporation (ADMP) Broker Price Targets For The Coming Week - Fiscal Standard
06/26/16 07:07 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Short Interest Increased By 40.68% - Press Telegraph
06/24/16 07:32 PMAdamis Pharmaceuticals Corporation (ADMP) Updated Price Targets - FTSE News
06/24/16 02:19 PMStock in Oversold Area: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Press Telegraph
06/21/16 07:05 AMRecently Issued Stock Ratings For Adamis Pharmaceuticals Corporation (ADMP) - Fiscal Standard
06/15/16 02:19 PMFive9, Inc. (NASDAQ:FIVN) Increased 2.78%: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Falconstor ... - KC Register
06/13/16 04:08 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other Events -
06/13/16 02:18 PMOversold Stocks: TransEnterix, Inc. (NYSEMKT:TRXC), Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Qunar ... - KC Register
06/12/16 09:20 AM7 Biopharma Companies That Destroyed Shareholders Last Week -
06/10/16 02:19 PMTwo Stocks within Traders Limelight: Galena Biopharma, Inc. (NASDAQ:GALE) , Adamis Pharmaceuticals Corporation ... - Street Updates
06/08/16 02:31 PMAnalyst Opinions on: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Flowers Foods, Inc. (NYSE:FLO) - Beacon Chronicle
06/07/16 10:42 AMThe Medicines Company (NASDAQ:MDCO) & Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Hot Healthcare Stock's ... - Wall Street 24
06/06/16 07:55 PMAnalysts Weigh In On Two Falling Biotechs: Adamis Pharmaceuticals Corp (ADMP), Immunomedics, Inc. (IMMU) - Smarter Analyst
06/06/16 12:48 PMStocks gain traction as Yellen plays down weak jobs report - [at MarketWatch] - U.S. stocks are trading higher after paring gains slightly in the wake of comments from Federal Reserve Chairwoman Janet Yellen, who on Monday cautioned that investors shouldn’t read too much into Friday’s ...
06/06/16 12:08 PMMylan Gains From Adamis Pain -
06/06/16 11:53 AMAdamis Pharmaceuticals Corp (ADMP) Stock Crashes on CRL for Epinephrine - Bidness ETC
06/06/16 07:13 AMUPDATE 1-FDA rejects Adamis' emergency drug for severe allergic reaction - June 6 (Reuters) - Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration rejected its emergency treatment for acute anaphylaxis, a severe allergic reaction, for the second...
06/04/16 10:46 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP), Exxon Mobil Corporation (NYSE:XOM), AT&T, Inc. (NYSE:T ... - KC Register
06/01/16 02:19 PMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Short Interest Increased By 41.05% - HNN - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Short Interest Increased By 41.05%HNNThe stock of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) registered an increase of 41.05% in short interest. ADMP's total short interest was 377,300 shares in June as published by FINRA. Its up 41.05% from 267,500 shares, reported previously.and more »
06/01/16 10:41 AMAdamis Pharmaceuticals Corporation (ADMP) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Adamis Pharmaceuticals Corporation (ADMP) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Adamis Pharmaceuticals Corporation (ADMP). The latest reports which are currently in issue on Wednesday 1st of June state 0 analysts have a rating of “strong buy”, 0 ...Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Short Interest Increased By 41.05%HNNall 2 news articles »
05/31/16 04:05 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/31/16 02:19 PMWeekly Biotech Report on upcoming FDA decision for Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Epinephrine pre-filled syringe for anaphylaxis - This one is an already established scientificly. It’s a reformulation of epinephrine (adrenaline), which is the hormone administered when individuals suffer from anaphylaxis, as an immediate response therapy. Anaphylaxis is an allergic reaction that ...
05/29/16 10:46 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Impact Score At 0 - RealistInvestor.com - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Impact Score At 0RealistInvestor.comAlpha One explored various online articles released on Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), and it set a daily sentiment score of 0.458 on the company. The entity has an algorithm in place to know stock sentiment on the share after ...and more »
05/27/16 11:01 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Sellers Increased By 41.05% Their Shorts - Wall Street Hints and News - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Sellers Increased By 41.05% Their ShortsWall Street Hints and NewsThe stock of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) registered an increase of 41.05% in short interest. ADMP's total short interest was 377,300 shares in May as published by FINRA. Its up 41.05% from 267,500 shares, reported previously.and more »
05/21/16 02:01 PMBroker Outlook For Adamis Pharmaceuticals Corporation (ADMP) - Share Trading News - Broker Outlook For Adamis Pharmaceuticals Corporation (ADMP)Share Trading NewsThe Company's product candidates for the treatment of asthma and chronic obstructive pulmonary disease (COPD) are APC-5000 DPI and APC-1000. The Company's other product candidates in its allergy and respiratory product pipeline include APC-1000, ...
05/21/16 02:01 PMRevenue Update on Adamis Pharmaceuticals Corp(NASDAQ:ADMP) - Trade Calls - Revenue Update on Adamis Pharmaceuticals Corp(NASDAQ:ADMP)Trade CallsAdamis Pharmaceuticals Corp(NASDAQ:ADMP) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 13, 2016. Company reported revenue of $0.00. Analysts estimated a revenue of $5.40M. Earnings ...Adamis Pharmaceuticals Corp (ADMP) Files Form 4 Insider Selling : David J. Marguglio Sells 4000 SharesMarket Digestall 4 news articles »

Social

About Adamis Pharmaceuticals Corp.

Adamis Pharmaceuticals Corp. logoAdamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADMP
  • CUSIP:
Key Metrics:
  • Previous Close: $2.98
  • 50 Day Moving Average: $3.02
  • 200 Day Moving Average: $5.51
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $42.59M
  • Beta: -0.16
Additional Links:
Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) Chart for Friday, July, 29, 2016